Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials

Fahim Ebrahimi, Carole Wolffenbuttel, Claudine A. Blum, Christine Baumgartner, Beat Mueller, Philipp Schuetz, Christian Meier, Marius Kraenzlin, Mirjam Christ-Crain, Matthias Johannes Betz

Source: Eur Respir J, 53 (2) 1800973; 10.1183/13993003.00973-2018
Journal Issue: February
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fahim Ebrahimi, Carole Wolffenbuttel, Claudine A. Blum, Christine Baumgartner, Beat Mueller, Philipp Schuetz, Christian Meier, Marius Kraenzlin, Mirjam Christ-Crain, Matthias Johannes Betz. Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials. Eur Respir J, 53 (2) 1800973; 10.1183/13993003.00973-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: